Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00526097
Status:
COMPLETED
Last Update Posted:
2014-01-15
First Post:
2007-09-05
Brief Title:
Dulcolax vs Placebo in Functional Constipation
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
A Randomised Double-blind Placebo-controlled Parallel Group Study to Assess the Efficacy and Safety of 4 Weeks Treatment With Bisacodyl Dulcolax Tablets 10mg Administered Orally Once Daily in Patients With Functional Constipation
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of the study was to compare the efficacy and safety of 4 weeks treatment with bisacodyl Dulcolax tablets 10 mg to placebo in patients with functional constipation In addition the effect of treatment on quality of life and general health status was evaluated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EUDRACT 2007-001991-34 | None | None | None |